Abstract
Objective: To determine safety and efficacy of gelatin-sealant filled in the access tract after tubeless percutaneous nephrolithotomy (PCNL). Material and Method: A randomized control trial study. 82 patients were divided into 2 groups, 41 patients for each group of with and without gelatin-sealant filled in the access tract. Changing of hemoglobin, blood transfusion, and post-operative complications were compared. Results: Decreasing of hemoglobin was 1.2 g/dl in group of gelatin-sealant and 1.5 g/dl in the other (p = 0.26). Blood transfusion was less in gelatin-sealant group than the other (2 units vs. 4 units, p = 0.63). Urethral catheter time was shorter in gelatin-sealant group (2 days vs. 3 days, p = 0.02). Others were not different. Conclusion: Gelatin-sealant in access tract after tubeless PCNL is safe to be an option to prevent bleeding in selected patients.
| Original language | English |
|---|---|
| Pages (from-to) | S132-S137 |
| Journal | Journal of the Medical Association of Thailand |
| Volume | 100 |
| Issue number | 3 |
| Publication status | Published - 2017 |
Keywords
- Gelatin sealant hemostatic agent
- Gelfoam
- Postoperative bleeding
- Tubeless PCNL
Fingerprint
Dive into the research topics of 'The impact of gelatin-sealant in the access tract after tubeless percutaneous nephrolithotomy: A randomized controlled trial'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver